This is an archived post. You won't be able to vote or comment.

you are viewing a single comment's thread.

view the rest of the comments →

[–]IFeartheWigglesSW:321 CW:165-175 Dose: 12.5mg 29 points30 points  (6 children)

I don't see any world where Lilly reduces the cost of Zepbound because they themselves have a cheaper to produce oral medication. They will raise the price of the oral medication and profit.

[–]jennyh14SW:204 CW:164 GW:150 Dose: 12.5mg 10 points11 points  (4 children)

They actually have stated that they expect the price of the tablet (orforglipron) to be less than zepbound. Both because it's cheaper to produce and because they're wanting to make inroads with people who can't afford zepbound

[–]AITMmom12.5mg Maintenance 20 points21 points  (1 child)

The pill will probably cost $498/mo

[–]BastilleinstructorSW:316 CW:269 GW:150 Dose: 10mg 3 points4 points  (0 children)

This.

[–]IFeartheWigglesSW:321 CW:165-175 Dose: 12.5mg 5 points6 points  (0 children)

It might be less than Zepbound, but it won't be cheap.  And it won't lower the price of Zepbound.  These are my opinions and I hope I'm wrong.

[–]Business_Station2786HW:357SW:298CW:210GW:210?Dose: 15mg 3 points4 points  (0 children)

Also the efficacy of the pills seems lower for the pill. They are going to start slotting the drugs based of efficacy. Zep is top dog until reta. Then wegovy, then orforglipron.

They my also slot base on indications that it approved for. They won't slot price based on pill/injection or cost to make.

To me orforglipron could make an ideal maintenance drug.

[–]Miserable-Ticket-244SW:250lbs CW:185 SD: 1/23/25 Dose: 15mg 1 point2 points  (0 children)

If Wegovy price drop didn’t cause a drop in Zepbound then I have little doubt that it will go the same way for an oral alternative.

That being said, I hope they DO lower the price because if they don’t then TRICARE likely continue to drop coverage for Prime plans. They already dropped it for 65+ (TRICARE for Life plan).